Acquisition
US filtration specialists Pall Corporation acquired GeneSystems, a privately held French biotechnology company that specialises in molecular diagnostics for identifying bacterial contamination. The technology is relevant to environmental, food and beverage and water markets.
GeneSystems was founded in 2000 in Bruz, France, to commercialise a Legionella diagnostics platform. Since this product was launched in 2004 the company has developed systems for the rapid and precise diagnosis of a range of pathogens, including food safety testing focused on E. coli.
“We are excited by this acquisition and the increased opportunities it presents for our pharmaceutical, biotechnology, environmental monitoring, quality control and diagnostics programs,” said Eric Krasnoff, Pall Corporation Chairman and CEO. “Customers seek better tools for rapid testing and process monitoring. GeneSystems expands our ability to provide Total Fluid Management to meet customer's raw materials, production, testing and environmental requirements.”
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.
